These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24117232)

  • 1. Medication adherence in a comparative effectiveness trial for bipolar disorder.
    Sylvia LG; Reilly-Harrington NA; Leon AC; Kansky CI; Calabrese JR; Bowden CL; Ketter TA; Friedman ES; Iosifescu DV; Thase ME; Ostacher MJ; Keyes M; Rabideau D; Nierenberg AA
    Acta Psychiatr Scand; 2014 May; 129(5):359-65. PubMed ID: 24117232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Single-Blind Randomized Comparison of Lithium and Lamotrigine as Maintenance Treatments for Managing Bipolar II Disorder.
    Parker G; Ricciardi T; Tavella G; Hadzi-Pavlovic D
    J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):381-388. PubMed ID: 34181361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
    Suppes T; Kroger H; Pikalov A; Loebel A
    J Psychiatr Res; 2016 Jul; 78():86-93. PubMed ID: 27089521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium.
    Nierenberg AA; Friedman ES; Bowden CL; Sylvia LG; Thase ME; Ketter T; Ostacher MJ; Leon AC; Reilly-Harrington N; Iosifescu DV; Pencina M; Severe JB; Calabrese JR
    Am J Psychiatry; 2013 Jan; 170(1):102-10. PubMed ID: 23288387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: contrasting LiTMUS baseline data with pre-existing placebo controlled trials.
    Friedman ES; Calabrese JR; Ketter TA; Leon AC; Thase ME; Bowden CL; Sylvia LG; Ostracher MJ; Severe J; Iosifescu DV; Nierenberg AA; Reilly-Harrington NA
    J Affect Disord; 2014 Jan; 152-154():97-104. PubMed ID: 23845385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescribing and monitoring lithium therapy: summary of a safety report from the National Patient Safety Agency.
    Gerrett D; Lamont T; Paton C; Barnes TR; Shah A
    BMJ; 2010 Nov; 341():c6258. PubMed ID: 21097572
    [No Abstract]   [Full Text] [Related]  

  • 7. Self-reported medication adherence and its correlates in a lithium-maintained cohort with bipolar disorder at a tertiary care centre in India.
    Singh S; Kumar S; Mahal P; Vishwakarma A; Deep R
    Asian J Psychiatr; 2019 Dec; 46():34-40. PubMed ID: 31590007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of medication adherence in a cohort of patients with bipolar disorder.
    González-Pinto A; Reed C; Novick D; Bertsch J; Haro JM
    Pharmacopsychiatry; 2010 Nov; 43(7):263-70. PubMed ID: 20842617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium toxicity and prolonged delirium.
    Albright A; Way RT
    Aust N Z J Psychiatry; 2017 Sep; 51(9):945. PubMed ID: 28829179
    [No Abstract]   [Full Text] [Related]  

  • 10. A population-based study of the comparative effectiveness of second-generation antipsychotics vs older antimanic agents in bipolar disorder.
    Bauer MS; Miller CJ; Li M; Bajor LA; Lee A
    Bipolar Disord; 2016 Sep; 18(6):481-489. PubMed ID: 27650468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining lithium and anticonvulsants in bipolar disorder: a review.
    Pies R
    Ann Clin Psychiatry; 2002 Dec; 14(4):223-32. PubMed ID: 12630658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial.
    Akhondzadeh S; Milajerdi MR; Amini H; Tehrani-Doost M
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):485-9. PubMed ID: 17042886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Putative Mechanisms of Action and Clinical Use of Lithium in Children and Adolescents: A Critical Review.
    Pisano S; Pozzi M; Catone G; Scrinzi G; Clementi E; Coppola G; Milone A; Bravaccio C; Santosh P; Masi G
    Curr Neuropharmacol; 2019; 17(4):318-341. PubMed ID: 29256353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication treatment perceptions, concerns and expectations among depressed individuals with Type I Bipolar Disorder.
    Sajatovic M; Jenkins JH; Cassidy KA; Muzina DJ
    J Affect Disord; 2009 Jun; 115(3):360-6. PubMed ID: 18996600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study.
    Calabrese JR; Ketter TA; Youakim JM; Tiller JM; Yang R; Frye MA
    J Clin Psychiatry; 2010 Oct; 71(10):1363-70. PubMed ID: 20673554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in BDNF (brain derived neurotrophic factor) and GDNF (glial cell line-derived neurotrophic factor) serum levels in bipolar disorder: The role of lithium.
    Tunca Z; Ozerdem A; Ceylan D; Yalçın Y; Can G; Resmi H; Akan P; Ergör G; Aydemir O; Cengisiz C; Kerim D
    J Affect Disord; 2014 Sep; 166():193-200. PubMed ID: 25012431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
    Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M;
    J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.